| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial Board
|
|
|
2012
|
48 |
2 |
p. ii-
1 p.
|
artikel
|
| 2 |
Gene therapy for amyotrophic lateral sclerosis
|
Federici, Thais
|
|
2012
|
48 |
2 |
p. 236-242
7 p.
|
artikel
|
| 3 |
Gene therapy for Huntington's disease
|
Ramaswamy, Shilpa
|
|
2012
|
48 |
2 |
p. 243-254
12 p.
|
artikel
|
| 4 |
Gene therapy for the treatment of chronic peripheral nervous system pain
|
Goins, William F.
|
|
2012
|
48 |
2 |
p. 255-270
16 p.
|
artikel
|
| 5 |
Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain
|
Kells, Adrian P.
|
|
2012
|
48 |
2 |
p. 228-235
8 p.
|
artikel
|
| 6 |
Introduction
|
Kordower, Jeffrey H.
|
|
2012
|
48 |
2 |
p. 151-152
2 p.
|
artikel
|
| 7 |
Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain
|
Cederfjäll, Erik
|
|
2012
|
48 |
2 |
p. 222-227
6 p.
|
artikel
|
| 8 |
Regulated protein expression for in vivo gene therapy for neurological disorders: Progress, strategies, and issues
|
Manfredsson, Fredric P.
|
|
2012
|
48 |
2 |
p. 212-221
10 p.
|
artikel
|
| 9 |
Translating the therapeutic potential of neurotrophic factors to clinical ‘proof of concept’: A personal saga achieving a career-long quest
|
Bartus, Raymond T.
|
|
2012
|
48 |
2 |
p. 153-178
26 p.
|
artikel
|
| 10 |
Use of viral vectors to create animal models for Parkinson's disease
|
Löw, Karin
|
|
2012
|
48 |
2 |
p. 189-201
13 p.
|
artikel
|
| 11 |
Viral-mediated overexpression of mutant huntingtin to model HD in various species
|
Ruiz, Marta
|
|
2012
|
48 |
2 |
p. 202-211
10 p.
|
artikel
|
| 12 |
Viral vectors for gene delivery to the central nervous system
|
Lentz, Thomas B.
|
|
2012
|
48 |
2 |
p. 179-188
10 p.
|
artikel
|
Tijdschrift beschrijving